1.中国藏学研究中心藏医药研究所,北京市朝阳区北四环东路131号,100101
2.北京中医药大学国家中医体质与治未病研究院
wangqi710@126.com
收稿:2022-08-14,
修回:2022-11-08,
纸质出版:2023-06-02
移动端阅览
罗辉,王琦.中医体质与新型冠状病毒感染相关性研究的系统评价和Meta分析[J].中医杂志,2023,64(11):1117-1123.
LUO Hui,WANG Qi.Correlation between Chinese Medicine Constitution and Coronavirus Diseases 2019 (COVID-19): A Systematic Review and Meta-analysis[J].Journal of Traditional Chinese Medicine,2023,64(11):1117-1123.
罗辉,王琦.中医体质与新型冠状病毒感染相关性研究的系统评价和Meta分析[J].中医杂志,2023,64(11):1117-1123. DOI: 10.13288/j.11-2166/r.2023.11.008.
LUO Hui,WANG Qi.Correlation between Chinese Medicine Constitution and Coronavirus Diseases 2019 (COVID-19): A Systematic Review and Meta-analysis[J].Journal of Traditional Chinese Medicine,2023,64(11):1117-1123. DOI: 10.13288/j.11-2166/r.2023.11.008.
目的
2
调查新型冠状病毒感染患者的中医体质分布特征以及体质与新型冠状病毒感染发生、转归的关系。
方法
2
检索中国知网、重庆维普、万方数据、PubMed和Web of Science数据库,纳入所有评价中医体质与新型冠状病毒感染相关性的临床研究。检索期限从2020年1月1日至2022年7月24日。结局指标为新型冠状病毒感染患者9种中医基本体质类型的分布比例、发病风险的比值比及其95%
CI
。采用观察性研究的国际相关评价标准对纳入研究进行方法学质量评价。
结果
2
共纳入10项临床研究,均为横断面研究,样本量总计1106例,所有研究均无一般人群对照组。在新型冠状病毒感染者中,痰湿质、气虚质所占比例分别为26%(95%
CI
:17%~38%)、20%(95%
CI
:13%~29%),平和质的比例为12%(95%
CI
:6%~22%)。亚组分析显示,不同病毒毒株、病情程度和年龄的患者体质构成有一定差异。2项研究的Meta分析显示:痰湿质与平和质的核酸转阴时间差异无统计学意义(
SMD
=0.48,95%
CI
:-0.52~1.49,
P
=0.35)。1项研究报告平和质的住院时间为(11.7±4.4)天,低于阴虚质的(19.7±8.5)天(
P
<0.05)。各研究的方法学实施要点报告比例普遍偏低,存在较高的偏倚风险。
结论
2
痰湿质和气虚质是新型冠状病毒感染者的主要体质类型,可能是其易感人群。体质与预后的关系研究证据不足,今后可视疫情形势变化开展基于不同地域、人群、毒株、感染次数等的中医体质与预后相关性的队列研究,为疾病防治提供参考。
Objective
2
To investigate the distribution of traditional Chinese medicine (TCM) constitution among the patients with coronavirus diseases 2019 (COVID-19), and the correlation between the TCM constitution and the occurrence and prognosis of COVID-19.
Methods
2
The China National Knowledge Infrastructure (CNKI), Chongqing VIP, Wanfang Data, PubMed, and Web of Science databases were searched from January 1st, 2020 to July 24th, 2022. Clinical studies evaluating the relationship between body constitution of TCM and COVID-19 were included. The primary outcome included the distribution of 9 TCM constitutional types among the COVID-19 population, risk ratio and odds ratio between constitution and COVID-19. Effect size was expressed as proportion or odds ratio with 95% confidence interval (
CI
). Methodological quality of included studies was evaluated by the international evaluation criteria for observational studies.
Results
2
Ten cross-sectional studies involving 1106 cases of COVID-19 were included. There was no control group of general population in all studies. Phlegm-dampness,
qi
-deficiency, and balanced constitution accounted for 26% (95%
CI
: 17%-38%), 20% (95%
CI
: 13%-29%), and 12% (95%
CI
: 6%-22%) of COVID-19 patients, respectively. Subgroup analysis showed that there were some differences in the constitution of patients with different virus strains, disease grades and age. Meta-analysis of two studies showed that there was no statistical difference in duration of nucleic acid turning negative between phlegm-dampness type and balanced constitution (
SMD
=0.48, 95%
CI
: -0.52-1.49,
P
= 0.35). One study reported that the hospitalization time was 11.7±4.4 days in patients with the balanced constitution, which was shorter than the 19.7±8.5 days in those with yin deficiency constitution (
P
<0.05). The methodological items of each study was generally poor in reporting, and suggested a high risk of bias among the studies.
Conclusion
2
Phlegm-dampness and
qi
deficiency are the main constitutional types of patients with COVID-19, and may be the susceptible population of COVID-19. There is few evidence about the relationship between constitution and prognosis of COVID-19. In the future, cohort study on the correlation between TCM constitution and prognosis could be carried out considering the factors of regions, populations, virus strains and infection times, in order to provide reference for the prevention and treatment of COVID-19.
ZHONG LL , WONG YP , LEUNG CY , et al . Effects of Chinese medicine for COVID-19 rehabilitation: a multicenter observational study [J]. Chin Med , 2022 , 17 ( 1 ): 99 .
CHEN K , CHEN H . Traditional Chinese medicine for combating COVID-19 [J]. Front Med , 2020 , 14 ( 5 ): 529 - 532 .
LUO H , TANG QL , SHANG YX , et al . Can Chinese medicine be used for prevention of Corona Virus Disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs [J]. Chin J Integr Med , 2020 , 26 ( 4 ): 243 - 250 .
王琦 . 中医体质学2008 [M]. 北京 : 人民卫生出版社 , 2009 .
李竹青 , 孙鹏程 , 秦静波 , 等 . 以新型冠状病毒肺炎为例探讨中医体质与外感疾病的关系 [J]. 安徽中医药大学学报 , 2020 , 39 ( 4 ): 1 - 4 .
中华中医药学会 . 中医体质分类与判定(ZYYXH/T157-2009) [J]. 世界中西医结合杂志 , 2009 , 4 ( 4 ): 303 - 304 .
ROSTOM A , DUBE C , CRANNEY A , et al . Evidence Reports/Technology Assessments , No . 104 . Appendix D. Quality Assessment Forms[M/OL]//Celiac Disease. Rockville (MD): Agency for Healthcare Research and Quality (US). (2004-09-01)[2022-08-14] . https://www.ncbi.nlm.nih.gov/books/NBK35156/ https://www.ncbi.nlm.nih.gov/books/NBK35156/ .
WELLS G , SHEA B , O'CONNELL D , et al . The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis [Z/OL].( 2019-04-01 )[ 2022-08-14 ]. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp .
罗辉 . 中医体质学体病相关临床研究的系统评价和方法学研究 [D]. 北京 : 北京中医药大学 , 2019 .
李少峰 , 黄春燕 , 印健铭 , 等 . 95例新型冠状病毒肺炎患者中医体质类型分布研究 [J]. 亚太传统医药 , 2021 , 17 ( 9 ): 3 - 6 .
丛晓东 , 杨金亮 , 李斌 , 等 . 30例新型冠状病毒肺炎核酸持续阳性患者临床特征回顾性分析 [J]. 中医杂志 , 2020 , 61 ( 24 ): 2121 - 2125 .
何红霞 , 张丽娟 , 范恒 . 新型冠状病毒肺炎患者中医体质研究 [J]. 中医学报 , 2020 , 35 ( 8 ): 1594 - 1597 .
杨家耀 , 苏文 , 乔杰 , 等 . 90例普通型新型冠状病毒肺炎患者中医证候与体质分析 [J]. 中医杂志 , 2020 , 61 ( 8 ): 645 - 649 .
陈威 , 张明昌 , 李敏 , 等 . 贵州省111例新型冠状病毒肺炎患者不同中医体质与临床特征分析 [J]. 世界最新医学信息文摘 , 2021 , 21 ( 102 ): 796 - 799 .
陈子琴 , 陈佳 , 陈贝 , 等 . 基于数据挖掘新型冠状病毒肺炎患者易感体质特征及用药规律 [J]. 北京中医药大学学报 , 2021 , 44 ( 3 ): 238 - 244 .
尚罗锐 , 杜超 , 刘宇寒 , 等 . 重型和危重型新型冠状病毒肺炎患者中医体质与证候类型及临床特征相关性分析 [J]. 辽宁中医药大学学报 , 2021 , 23 ( 4 ): 61 - 64 .
张雄慧 , 张常喜 , 童安荣 , 等 . 宁夏回族自治区新型冠状病毒肺炎中医体质类型与临床特征分析 [J]. 中国民族民间医药 , 2022 , 31 ( 7 ): 12 - 14, 31 .
郑芳萍 , 李娜芬 , 李晨瑶 , 等 . 基于真实世界研究厦门本土183例新型冠状病毒Delta变异株感染患者的临床特征及中医体质分布规律 [J]. 中医药通报 , 2022 , 21 ( 2 ): 41 - 45 .
任婕 , 李志更 , 王宪波 . 北京地区Alpha变异株新型冠状病毒肺炎患者中医证候与体质分析 [J]. 中医学报 , 2022 , 37 ( 8 ): 1770 - 1774 .
王琦 , 朱燕波 . 中国一般人群中医体质流行病学调查:基于全国9省市21948例流行病学调查数据 [J]. 中华中医药杂志 , 2009 , 24 ( 1 ): 7 - 12 .
白明华 , 王济 , 郑燕飞 , 等 . 基于108015例样本数据的中国人群中医体质类型分布特征分析 [J]. 北京中医药大学学报 , 2020 , 43 ( 6 ): 498 - 507 .
郑文科 , 张俊华 , 张军 , 等 . 2135例新型冠状病毒肺炎患者中医证候调查分析 [J]. 中医杂志 , 2021 , 62 ( 16 ): 1413 - 1415 .
王琦 , 李英帅 , 李玲孺 , 等 . 针对复工复产复学后新型冠状病毒肺炎聚集性传染隐患的中医药防控 [J]. 中医杂志 , 2020 , 61 ( 21 ): 1841 - 1845 .
罗辉 , 王琦 . 中医体质与疾病相关性临床研究的方法学挑战和设计实施建议 [J]. 中医杂志 , 2020 , 61 ( 1 ): 20 - 26 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号